Previous 10 | Next 10 |
TEL AVIV, Israel , March 25, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that the Company will host a conference call on...
TEL AVIV, Israel , March 19, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that it has entered into a securities purchase ag...
TEL AVIV, Israel , Feb. 27, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that on February 24, 2020, the Company received a written not...
TEL AVIV, Israel , Feb. 6, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that on February 5, 2020, it received notice that the Nasdaq H...
Gainers: Trillium Therapeutics (NASDAQ: TRIL ) +106% . More news on: Trillium Therapeutics Inc., Applied Genetic Technologies Corporation, Genetic Technologies Limited, Stocks on the move, Read more ...
Tufin Software Technologies (NYSE: TUFN ) -24% on Q4 guidance cut . More news on: Tufin Software Technologies Ltd., Therapix Biosciences Ltd., SELLAS Life Sciences Group, Inc., Stocks on the move, Read more ...
Thinly traded nano cap Therapix Biosciences (NASDAQ: TRPX ) prices its direct offering of 1M American Depositary Shares (ADSs) at $1.25 per ADS. More news on: Therapix Biosciences Ltd., Healthcare stocks news, Stocks on the move, Read more ...
TEL AVIV, Israel , Dec. 4, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. (" Therapix " or the " Company ") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced that it has entered into definit...
TEL AVIV, Israel , Dec. 2, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or the "Company") (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today the progression of its RESPECTRUM pro...
Therapix Biosciences ( TRPX -3.9% ) says it received a de-listing notice from Nasdaq, a decision the company says it will appeal. More news on: Therapix Biosciences Ltd., Healthcare stocks news, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Therapix Biosciences Ltd. Company Name:
TRPX Stock Symbol:
NASDAQ Market:
TEL AVIV, Israel , Aug. 21, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today the replacement of its board of directors. The Comp...
TEL AVIV, Israel , July 9, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today that its American Depositary Shares ("ADSs") will no...
TEL AVIV, Israel , July 1, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) (the "Company" or "Therapix"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today receipt of Notice of Delisting and Inju...